APR 07, 2015 06:41 PM PDT

High Number of Mutations Means Better Cancer Survival Rate

WRITTEN BY: Will Hector
DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led comprehensive genomic analysis of more than 700 brain tumors has revealed one such subtype of the most malignant brain tumor, called glioblastoma, or GBM. This subtype possesses thousands of tumor-specific DNA errors or mutations instead of dozens observed in most glioblastoma cases. It is also associated with longer survival.

The findings, reported in Journal Neuro-Oncology, suggest it may be possible to develop personalized treatments for more aggressive forms of brain cancer, including immunotherapy for these hyper- or ultra-mutated tumors, said Murat Günel, professor and chair of neurosurgery, who leads the Yale Program in Brain Tumor Research at Yale and Smilow Cancer Hospital at Yale-New Haven.

"We have been able to translate various complementary cutting-edge genomic technologies, which were once solely research tools, to our clinical programs to analyze individual cancers," said Günel, who is also a professor of genetics and a researcher for the Yale Cancer Center. "We can now gain comprehensive understanding of the molecular make-up of a cancer to pinpoint specific vulnerabilities and leverage these weak spots for precision treatments in our Recurrent Brain Tumor Treatment Program."

While as many as 10,000 mutations were found in the newly described subset of glioblastomas, a more typical tumor contains less than 100. This counterintuitive pattern has also been observed in gynecological and colon cancers: An extraordinary number of mutations means a better chance of survival.

One theory holds that cells with greater number of mutations are able to trigger an aggressive immune system response against cancer cells, while cells with fewer mutations might escape detection, Gunel said.

Although the number of GBMs in this newly identified group is small, the use of standard chemotherapy in some cases has been shown to inadvertently result in a hyper-mutated tumor. Indeed, the drug temozolomide, used as the first line of chemotherapy in GBM, has been shown to sometimes increase mutations.

"But perhaps the naïve immune system is not strong enough to eliminate the cancer cells in these brain tumors," Gunel noted.

However, if a new generation of immunotherapy drugs called checkpoint inhibitors were used in these hyper-mutated tumors, perhaps more cancer cells might be targeted for destruction, he said. Clinical trials currently underway might be improved by considering the molecular genetic make-up of the individual tumor, he concluded.

Follow Will Hector: @WriteCompassion

(Source: Yale Cancer Center; Science Daily)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
SEP 22, 2019
Microbiology
SEP 22, 2019
Rising Cases of Encephalitis and Death in India
Children in eastern India have been dying of encephalitis. Around 400 kids have complained of dizziness, confusion and fever since the start of the year....
SEP 22, 2019
Genetics & Genomics
SEP 22, 2019
Do We Inherit Our Instincts?
Some things are just instinct. For example, a mother’s urge to look after her young is generally considered an instinct, as is a spider’s abili...
SEP 22, 2019
Neuroscience
SEP 22, 2019
Scientists use AI to reveal an unexpected role for "junk" DNA in autism
According to a new study published in Nature Genetics, spontaneous mutations or "junk" DNA that occur between genes may turn out to be key to understanding autism. This study was the first to...
SEP 22, 2019
Neuroscience
SEP 22, 2019
Naturally produced psychoactive chemical DMT discovered in mammal brains
In recent years, celebrities and thrill-seekers, as well as those seeking treatment for post-traumatic stress disorder (PTSD) have traveled to South Americ...
SEP 22, 2019
Plants & Animals
SEP 22, 2019
Crows Can Be Silent If They Choose to Be
Researchers have long thought that songbirds unleash their colorful vocalizations involuntarily in response to activities happening around them, such as fo...
SEP 22, 2019
Technology
SEP 22, 2019
App Offers Assessment for Multiple Sclerosis
Scientists at Johns Hopkins Medical School have reported on a new tablet-based app development concerned assessing cognitive function in a fast and accurat...
Loading Comments...